Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (686)	11/3/1997 12:08:00 PM
From: luis a. garcia	Read Replies (1) \| Respond to of 1115

Road trip didn't do much for the stock price... its a market thing.. if there are no earnings.. then there is no support to go higher.. I am a bit disapointed because the momemtum and the rotation are away from biotecs.. perhaps after they produce the NDA. Peer review article is taking time.. Kaposi's took 3 months or so to get published.. still there is lift in the stock and we should see the 4 dollar level by Jan.. luis

To: John Zwiener who wrote (686)	11/6/1997 11:48:00 AM
From: donald barton	Read Replies (1) \| Respond to of 1115

I spoke to Lisa Katz at IR. She confirmed that no new information from the most recent trial was presented at the recent road shows. She stated that the new information (time to healing,etc.) was withheld at the request of their partners. Investors who are long and believe in this company, will again have to trust that this representation is not manipulative. She also indicated that the NDA will be submitted before the end of the year. What do you think John?